Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmet Kadıoğlu
Observed names:
Ahmet Kadioglu,
Ahmet Kadıoglu,
Kadioglu, Ahmet,
Kadıoğlu, Ahmet
Institution:
Balıkesir Atatürk City Hospital
Observed institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital,
Balıkesir Atatürk City Hospital
ORCID:
0009-0002-4464-314X
Observed ORCID:
0009-0002-4464-314X
OpenAlex ID:
A5087340874
The mediating effect of intrusive rumination on the relationship between illness uncertainty and fear of cancer recurrence in breast cancer survivors
2025
·
Alper Türkel
, Nur Nihal Türkel
, et al.
·
BMC Women s Health
·
10
PDF
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024
·
Yusuf Ilhan
, Gokhan Ucar
, et al.
·
Expert Opinion on Pharmacotherapy
·
8
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
2024
·
Arif Akyildiz
, Deniz Can Guven
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
8
“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
2025
·
Serkan Yaşar
, Ahmet Kadıoğlu
, et al.
·
Medicina
·
3
PDF
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
2024
·
Murat Bardakci
, Hilal Karakas
, et al.
·
Scientific Reports
·
1
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study
2024
·
Serhat Sekmek
, Irfan Karahan
, et al.
·
Clinical & Translational Oncology
·
1
Low baseline breast TLG and axillary MTV independently predict pathological complete response in HR-positive/HER2-negative breast cancer
2026
·
Zeynep Akar
, Hasan Bozkurt
, et al.
·
BMC Cancer
Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab
2026
·
Seray Saray
, Berke Engin
, et al.
·
BMC Cancer
A retrospective multicenter study on solitary fibrous tumors: investigation of clinical features and management approaches
2025
·
Serkan Yaşar
, Feride Yılmaz
, et al.
·
Journal of Health Sciences and Medicine
PDF
Soliter fibröz tümörler üzerine retrospektif çok merkezli bir çalışma: klinik özellikler ve tedavi yaklaşımlarının incelenmesi
2025
·
Yaşar, Serkan
, Yılmaz, Feride
, et al.
·
Journal of Health Sciences and Medicine
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study
2025
·
Serhat Sekmek
, Aysel Oguz
, et al.
·
Journal of Clinical Medicine
PDF
Comparison of the Efficacy and Safety of Docetaxel-Trastuzumab-Pertuzumab (DTP) with Standard 4-Doxorubicin and Cyclophosphamide (AC)-Taxan-Trastuzumab-Pertuzumab in Neoadjuvant Treatment of Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER-2) Positive Breast Cancer: a Turk Oncology Group (TOG) study.
2023
·
Murat Bardakci
, Hilal Karakas
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
13
Citation count:
31
H-index:
3
I10-index:
1
Year
Topic
Type